Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation.
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 66 (5) , 1449-1452
- https://doi.org/10.1161/01.res.66.5.1449
Abstract
The antiperoxidative activities of nifedipine, verapamil, and diltiazem were compared with that of propranolol by using an in vitro model of sarcolemmal membrane lipid peroxidation. Highly purified sarcolemmal membranes, isolated from canine ventricular myocytes, were peroxidized by a superoxide anion-producing and iron-catalyzed free radical-generating system (dihydroxy-fumarate plus FeCl3 and ADP). Lipid peroxidation after 20 minutes of incubation was monitored by malondialdehyde formation. Similar to propranolol, all three calcium blockers exhibited concentration-dependent (10-400 microM) inhibitory effects against sarcolemmal lipid peroxidation. The order of potency of these agents was nifedipine greater than propranolol greater than verapamil greater than diltiazem. Nifedipine, the most effective calcium blocker, was greater than twofold more potent than propranolol and achieved a significant effect at 10 microM. This study suggests that calcium blockers may provide antiperoxidative protection to cardiac membranes.This publication has 18 references indexed in Scilit:
- Partition of ca2+ antagonists in brain plasma membranesBiochemical Pharmacology, 1989
- Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptorsJournal of Molecular and Cellular Cardiology, 1989
- Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide productionFree Radical Biology & Medicine, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilitiesBiochemical Pharmacology, 1984
- Clinical Pharmacokinetics of VerapamilClinical Pharmacokinetics, 1984
- The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heartBasic Research in Cardiology, 1982
- Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazemThe American Journal of Cardiology, 1980
- Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardiumThe American Journal of Cardiology, 1980
- The role of superoxide radical in a nonenzymatic hydroxylationArchives of Biochemistry and Biophysics, 1972